Laserfiche WebLink
5.0 ASSESSMENT OF RISK AND BENEFICIAL USES <br /> 1 <br /> To assess whether residual hydrocarbon constituents in soil and ground <br />' water at each former UST site pose an unacceptable risk to human health <br /> under current and realistic future land use conditions, a health risk <br /> assessment (HRA) was conducted The HRA methodologies, <br />' assumptions, and results are presented below <br />' The approach used to develop the HRA followed methodologies outlined <br /> by the American Society for Testing and Materials (ASTM) as described in <br /> their Standard Guide for Risk-Based Corrective Action Applied at Petroleum <br />' Release Sites (E1739-95, ASTM, December 1996) In developing this <br /> analysis, modifications were made to ASTM's general procedures to <br /> incorporate applicable guidance issued by the California Environmental <br /> 1 Protection Agency (Cal-EPA) and the U S Environmental Protection <br /> Agency (USEPA) <br />' Consistent with the ASTM methodology, development of site-specific, <br /> risk-based screening levels for the former tank sites entailed three major <br /> steps, as follows <br /> o Identification of constituents of potential concern in each medium (i e , <br /> soil and ground water) <br /> o Identification of realistic exposure pathways associated with each <br /> medium <br /> Development of risk-based screening levels for each medium, using <br /> appropriate exposure assumptions and current toxicity information <br />' from Cal-EPA and USEPA <br /> Each of these steps is described in the following subsections <br />' 51 IDENTIFICATION OF CONSTITUENTS OF POTENTIAL CONCERN <br /> Despite the remedial activities conducted at each former tank site, some <br />' residual constituents remain in subsurface soils and ground water <br /> Specific constituents found in post-remediation samples include BTEX <br /> compounds All of these constituents are commonly associated with <br />' weathered gasoline, and all were considered constituents of potential <br /> concern for the purposes of the HRA <br />' ERM 18 HEINZ USA 3374 60-3/27/00 <br />